Part detail
Clorazepate Dipotassium Tablets
4389-53NSN6505-01-252-0802CAGE70048
Clorazepate Dipotassium Tablets
Detailed description
4389-53 procurement notes
Clorazepate Dipotassium Tablets
Specifications
Reference data
Multi-line procurement
Sourcing more than one part?
Upload a bill of materials (BOM) or paste a list of part numbers — every line bundles into a single RFQ. No checkout, no payment.
Compliance
- AS9120:2025· Aerospace QMS
- ISO 9001:2015· Quality Management
- FAA AC 00-56B· Voluntary Industry Distributor Accreditation
- U.S. ONLY· Fulfillment
NSN Information for Part Number 4389-53 with NSN 6505-01-252-0802, 6505012520802
Characteristics Data of NSN 6505-01-252-0802, 6505012520802
| MRC | Criteria | Characteristic |
|---|---|---|
| AJCN | PROTECTIVE STORAGE FEATURE | SECURITY STORAGE |
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 3.750 MILLIGRAMS CLORAZEPATE DIPOTASSIUM ACTIVE INGREDIENT |
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 500.000 TABLETS |
| FEAT | SPECIAL FEATURES | SCHEDULE IV CONTROLLED SUBSTANCE CLASSIFICATION |
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | CLORAZEPATE DIPOTASSIUM TABLETS 3.75MG 500S BT |
| CQCT | PRIMARY CONTAINER TYPE | BOTTLE |